Juliana Choi
Family · Fairfax, VANPI 1336178516
Payments from drug & device makers
Across 116 payments — averaging $20.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$553
- Boehringer Ingelheim$326
- Novo Nordisk$314
- AstraZeneca$179
- Lilly USA, LLC$169
- Johnson & Johnson$136
- plus $749 from 17 others
What the payments were for
- Food & beverage$2,38398%
- Education$432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 21 | $553 |
| Boehringer Ingelheim | 14 | $326 |
| Novo Nordisk | 17 | $314 |
| AstraZeneca(2 entities) | 8 | $179 |
| Lilly USA, LLC | 10 | $169 |
| Johnson & Johnson | 7 | $136 |
| Amarin Pharma, Inc. | 5 | $106 |
| Amgen | 6 | $100 |
| GSK | 4 | $79 |
| Pfizer | 3 | $69 |
| Bayer | 3 | $63 |
| Exact Sciences | 3 | $59 |
| Astellas Pharma US Inc | 3 | $53 |
| OPKO Pharmaceuticals, LLC | 2 | $43 |
| AbbVie | 2 | $43 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Abbott | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| VBI Vaccine (delaware) Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Metacel Pharmaceuticals LLC | 1 | $10 |
How this compares
$2,426 in reported general payments places this provider in the 85th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $15,142 |
| PaxlovidNirmatrelvir/Ritonavir | 15 | $1,429 |
| Atorvastatin Calcium | 89 | $455 |
| Losartan Potassium | 30 | $227 |
| Rosuvastatin Calcium | 50 | $150 |
| Tamsulosin Hcl | 12 | $130 |
| Pioglitazone Hcl | 17 | $116 |
| Metformin Hcl | 26 | $110 |
| Amlodipine Besylate | 48 | $103 |
| Ciprofloxacin Hcl | 11 | $62 |
| Alendronate Sodium | 15 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $326 | $15,14211 claims |
| PfizerPaxlovid | $69 | $1,42915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,332 family providers in Virginia.
Other family in Fairfax
- Meagan AdamsonFairfax$34K
- Christine HelouFairfax$28K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.